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Rheumatoid Arthritis and Osteoarthritis
Liza Dunkley 
Senior Lecturer In Podiatry
University of Huddersfield
(some slides modified from Jenny Tranter)
Aims
 Medication management
 Review  the podiatric implications of  Rheumatoid 
Arthritis and Osteoarthritis
 Management of foot problems in early and established 
Rheumatoid disease
 Explore the management of the prevention and 
treatment of ulceration in the high risk foot.
 Podiatric management
 MSK /Functional – orthotic mangement
 High risk / Tissue viability - Woundcare
Medication in Rheumatoid Arthritis
 Simple analgesics
 NSAIDs
 Corticosteroids
 DMARDs mono and or  
combination
 Biologic therapies TNF
 Chronic pain drugs
 Complementary therapy
X
Medical management 
principles
 New concept 
 Detect and refer EARLY
 intervene aggressively
 Patients newly diagnosed with RA offered a 
combination of DMARD’s as 1st line treatment
 Principles of ‘TIGHT’ control/treat robustly
 Minimise inflammation to improve ALL outcomes 
for the patient
Step down approach
‘Inverted triangle’
Disease Modifying Anti-Rheumatic 
Drugs (DMARDs)
 Suppress disease activity
 Reduce pain, swelling, stiffness of joints
 Slow onset of action 
 Nearly all require regular blood monitoring
 Choice depends on balancing side-effects with efficacy
 High toxicity
RA NICE guidelines 
overview
 Monitor response and toxicity
 In newly diagnosed 
 combination of DMARDs
 If combination therapy not appropriate, start monotherapy but place 
greater emphasis on suppression of inflammation
 If patient has not responded to above consider Biologic Therapy if 
indicated 
 Cost implications
 DAS score
Feldman M, et al. Annu Rev Immunol. 1996;14:397-440.
Biologic Therapies
 Adalimumab (Humira) (anti TNFα) – subcut. Injection, 
every other week or weekly
 Anakinra (Kineret) (anti IL1) – subcut. Injection, daily
 Etanercept (Enbrel) (anti TNFα) – subcut. Injection, once 
or twice weekly
 Infliximab (Remicade) (anti TNFα) - IV
 Rituximab (Mabthera) (anti CD20)– IV
Limitations
 Cost considerations (£6-8k per annum)
 At what stage?
 1st line in USA
 NICE UK guidelines
 Fail 2 DMARDs
 Treatment complications
 Injection-site reactions
 Infection
 Malignancy
 Clinical efficacy?
Biologic Therapy Alerts
 greater risk of infection
 should be stopped with serious infections
 Post surgery Biologics should not re-commence until wound 
healing demonstrates good prognosis
 GP/Consultant must be consulted prior to any surgical 
intervention
 Patients on Biologic Therapy and with foot deformity and/or 
poor tissue viability should receive regular Podiatry 
appointments
Steroids
 Anti-inflammatory & may slow disease progression
 Systemic treatment: many side effects Dose/duration 
dependent
 Side effects include osteoporosis, diabetes, hypertension
 Oral prednisolone- most risk of SE’S
 Intra-articular injections
 I.M injections
 I.V infusions
 Podiatric implications
 Fibro fat pad atrophy, delayed healing
Local steroid Injection Therapy
 Widely used
 Easy and safe
 Deliver potent treatment locally with minimal side-
effects
 Can be administered by AHP’s
Rheumatoid Arthritis
Podiatric Implications
Foot - Epidemiology
 2nd most frequent site of symptoms
 79-94% will have foot symptoms/deformity
 Most suffer at onset of disease 
 Development & severity increase with duration of active 
joint disease
 Differentiating MSK pathology as a result of functional 
changes  in foot function and the signs of active disease 
process
Changes in foot function And Structure 
In Rheumatoid Arthritis
Structure
 Combination of inflammatory 
process and abnormal 
mechanical loads
 Synovitis - stiffness
 Erosions
 Deformity
 Displaced fat pad
 Subluxation
Function
 Limited joint mobility
 Proprioception
 Poor postural stability and 
instability in gait
 Excess foot pronation / 
supination
 Changes in foot function-
predispotion to overuse
 Limitation of movement -
muscle wasting
Tissue Damage
Risk of infection / Risk of impaired healing
 Direct mechanical trauma
 Constant Intermittent moderate pressure
 Deformities
 Poor Tissue Viability
 Immuno compromised
 PAD  Vasculitis
 Neuropathy
 Anaemia
 Risk of co mobitities
Podiatric 
Management
Dx Assessment
Monitoring
Education 
Empower-
ment and 
support
Palliative 
treatment
MSK
Tissue 
Viability and 
wound care
Pressure Relief 
and ulcer 
prevention
Liaison




Clinical Manifestations
 Synovitis
 Bursitis
 Hallux Abductor valgus
 Lesser toe deformities
 Subluxation of MTP joints 
 Callosities
 Ulceration
 Nodules
 Vasculitis
 Nail infarcts
Clinical Manifestations MSK  and Functional 
 Synovitis
 Tenosynovitis
 Pes planovalgus deformity:
 Flattening of medial longitudinal arch
 Valgus deformity of calcaneus
 Tibialis posterior degeneration -------- Adult acquired flat 
foot deformity-------subluxation
Assessment
 Neuropathy
 Ischaemia
 Deformity
 Musculoskeletal
 Dermatological
 Infection
 Osteomyelitis
 Joint damage
 Extra articular
 Footwear
 Woundcare
 Well Being
 Function
 Support
 Pain
 Fatigue
 Disease Activity
Monitoring and Assessing disease 
activity in the foot
 Monitor patient overtime using outcome measures to predict 
further outcome
 Assess disease activity at each appointment
 DAS score, blood results, localised inflammation, changes to patient 
daily activities
 Assessment of joint loading patterns
 Gait parameters
 Documentation and assessment of joint deformity
 Soft tissue assessment 
 Muscle power testing
 Pos Tib dsyfunction/tinnel’s sign
Treatment - Callus debridement
 To debride or not to debride?
 Woodburn et al (2000)
 Plantar callosities of 14 RA patients feet debrided, pain scale using VAS 
reported symptomatic relief but treatment effect lost after 7 days.  
Following scalpel debridement, contact time reduced but peak pressure 
increased.  Conclusion – scalpel debridement may reduce forefoot pain  
for 7 days but pressure distribution not affected
 Davys et al (2005)
 Compared forefoot pain, pressure and function after normal and sham 
callus debridement.  No statistical difference overall.  Improvement 
overall short lived.  Conclusion – forefoot pain may not be soley 
attributed to plantar callosities
Liason
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Pressure Relief and Functional 
Considerations for Orthotic 
Therapy
Functional insoles and therapeutic footwear 
should be available for all people with RA if 
indicated. 
NICE 2009
Progressive Deformity
Management of joint damage 
pain and disability
 Impaired structure and function
 Fluctuating nature of synovitis effect ROM
 Orthosis design is dependant on ROM not disease 
duration
 Deformity
 Synovitis and mechanical stress
 Minimise pain and deformity
Management in Early Disease
 referred to Podiatry for early baseline assessment of foot health needs 
(ARMA, 2004)
 Patient education
 Footwear appraisal
 Minimise effects of joint loading and deformity
 Biomechanical screening,
 off loading strategies - forefoot
 Rigid and functional/controlling orthoses
 Baseline record of disease activity and serology
 Baseline outcome measures included in management plan
Established RA
 Minimise progressive change
 Orthotic design should move away from rigid device and offer a 
mix of support and control
 Orthotics should incorporate materials that decelerate pressure 
 Maintain mobility
Late stage disease
 Late stage disease
 Established pes planus deformtity
 Minimise progressive change
 Service provision with increased emphasis on MST involvement 
 Total contact insoles
 Management of secondary features 
 Regular access to emergency appointments for prompt management of 
vasculitis, soft tissue lesions and ulceration 
 Maintain mobility
Changes in gait style –
established RA
 Decreased gait velocity and cadence
 Increased double support
 Decreased contact time loading of forefoot
 Delayed heel lift
 Increased loading in force time curves
 Flatter foot contact
 Increased contact area and duration of mid foot
D Turner 2008; van der Leeden 2008
Red flags!
 Early referral to Rheumatology
 > 3 swollen joints, MTP and MCP involvement, Positive squeeze test
 N.B. NSAIDs can mask signs and symptoms at presentation
 Patients presenting with infection and receiving biologic therapy
 Reactive arthritis should be considered if present with inflammatory 
arthritis localised to multiple joints in the  lower limb 
 Infective arthritis should be considered in the case of monoarthritis
in the foot following surgery or injury.  Rapid referral for further 
imaging and haemitological investigation is warranted
Orthotic Management
Functional – Early disease
 Prevent joint damage
 Mobile feet 
 Reduce foot pain
 optimise foot function
 Slow rate of progression of 
deformity heel and ankle early 
RA (Woodburn 2003)
Pressure Redistributing 
Insoles- Established
 Improve comfort 
(Hodge et al 1999)
 maximise foot function
 Increase shock absorption
 Reduce shear?
 Functionally stabilise arch
 Decrease pain
 Protection / tissue viability
Woodburn et al 2005 2003 clark 2006
Foot Pressure Measurement in 
Rheumatoid Arthritis 
 Ulceration at sites of maximum pressure- forefoot 
(Hodge et al 1999 van der Leeden et al 2006)
 High forefoot pressures result in pain
 Radiological erosion scores – high pressure (Tuna 2005)
 Footwear / orthoses to reduce pp do not always  
relieve pain
Methods of Pressure Relief
 Padding & Strapping
 Orthoses TCI semi functional
 Total non Weight bearing
 Shoe modifications /half 
shoes
 Footwear
 Soft cast /scotch cast
 Total contact casting
 Temporary- allergy/ 
restriction of circulation of 
loops/ elastic
 Footwear accomodation
 Impractical, costly. Muscle 
wasting, DVT, 
 Poor compliance
 If rocker in the wrong 
position increases pressures
 Experienced Plaster 
technician
 Infection
Total Contact Inlays
 Aim is to redistribute pressure by increasing the weight 
bearing area of the foot
 Prevention of tissue breakdown
 Healing of damaged tissues
 Protection of high pressure areas 
 Pressure important contributing factor to ulceration
 Peak pressure over ulcer sites has been shown to be up to 
15x greater than normal (Boulton et al 2000)
 Footwear needs to be appropriate
 Materials need to be chosen well – may be some 
compromises
Soft Cast
Rigid AFO
Hinged AFO
Posterior Leaf Spring
Dynamic AFO
New patient with Ulceration to 
plantar 2 nd MTPJ
 Biologic therapy / HAV and Lesser MTPJ damage
 Management ?
OsteoArthritis
DJD
Podiatric Implications
Lower limb and Foot 
manifestations
Effect on function 
 Assymetry LLD
 Spine 
 Hip 
 Knee 
 Ankle
 STJ
 Midfoot
 1 ST mtpj
 Lesser Digits DIPJ
 DJD, disc prolapse,radicular
symptoms
 LLD – internal rotation
 LLD – Varus
 Loss of foot pivots
 Shock absorption
 Pain 
 Deformity
 Gait
Osteoarthritis Treatment
 Mediterranean diet
 Glucosamine
 Chondroitin
 Pain control – NSAIDs and analgesia
 Weight-loss 
 Surgery / Joint Replacement
 Exercise therapy
 Activity modification
 Podiatry 
Hallux Limitus/Rigidus
Drago/Regnauld Grades
Grade 1:
Functional Hallux Limitus
Grade 2:
Mild Hallux Limitus - Joint 
adaptation
Grade 3:
Moderate Hallux Limitus -
O.A.
Grade 4:
Severe Hallux Limitus -
Ankylosis,  
46
47
Cartilage damage in the 
dorsiflexed ray
 Base of Proximal 
Phalanx collides into 
cartilage.
 elevates cartilage
 Damage & subsequent 
OA occurs.
48
Hallux Limitus Complex
 Limited 
dorsiflexion at 
MPJt
 Hyperextension 
at IPJt
49
Hallux RigidusManagement
 Exostosis
 Bursa
 Limited ROM MPJt
 Hyperextended IPJt
 Callus sub IPJt
 OX
 OP
 Subungual exostosis
Podiatric Interventions
 Footwear advice
 Pacing (graded activities)
 Education & Empowerment (Arthritis Care free course)
 Exercise - Muscle strength & Flexibility
 Biomechanical examination/Orthoses – enhance 
function or limit movement, pressure redistribution
 LA / steroid injection
 Ostenil injection
 Podiatric Surgery referral
 Referral Orthotist
51
Wear marks in 
Hallux Rigidus
Conservative ROCKER SOLE
 Rigid soled footwear
 Rocker sole
 Curved heel
 Encourage forward progression 
when there is restriction of 
motion at a foot pivot
Hallux limitus
Orthoses
Kinetic wedge 1
st Ray cut out
54
Treatment
 Joint preservation
 Cheilectomy
 Watermann
decompression osteotomy
 Kessel -Bonny
 Joint destruction
 Kellers arthroplasty
 Arthrodesis
 Joint replacement
 Silastic arthroplasty
55
Arthrodesis vs. joint 
replacement
 Arthrodesis
 Strong 1st ray
 For active lifestyle
 Usual 80% + success
 Nonunion
 Malunion
 OA ipj
 Joint replacement
 Range of movement
 Footwear 
 ? Success rates
 ? Longevity
 ? Sesamoid problems
 ? Metatarsalgia
56
Fusion
Intreposition bone 
graft & good union 
at 8 weeks
57
Titanium 
Implant 
Arthrodesis
58
Reflection & Swanson total 
joint systems
Conclusion
Case study A
 Early stage RA – Flexible pes planus, tib post dysfunction, 
symptoms
 Restricted ankle joint and MTJs due to synovitis which is 
improving 
 Patient is also seeing physiotherapist and is under 
Rheumatologists and is taking biological therapy
Case study B
 Osteoarthritis severe of ankle knees and 1 st MTPJ fixed 
plantar flexed 1 s Ray
 Laterally unstable ankle and associated symptoms
 Limited ROM at STJ and fixed varus heel deformity  


Case Study C
 SLE
 Large areas of plantar vasculitis whole of sole of foot
 Long standing
 Poor tissue viability – due to long-term steroid 
medication
 Patient reluctant to change foot wear slip on narrow shoe 
no fastening
 Shuffling gait but reasonable ROM most joints
Case study D
 RA - 78
 Established disease
 Restricted ROM 
 Gross digital deformities
 Prominent MTPJ’s bursa with longstanding ulceration to 3 
rd MTPJ  
 Varus heel
Professional Organisations
 PRCA
 http://www.prcassoc.org.uk
 BHPR
 http://www.rheumatology.org.uk
 ARMA
 http://www.arma.uk.net/
 EULAR
 http://www.eular.org/
Information Sources
 Arthritis Research Campaign
 Patient leaflets/informative literature
 Educational/Professional literature
 GALS/REMS
 Collected Reports on Rheumatic Diseases
 Arthritis and Musculoskeletal Alliance
 www.arma.uk
 Standards of Care for people with musculoskeletal foot health problems
 PRCA. Available at: http://www.prcassoc.org.uk/standards-project
 NRAS. National Rheumatoid Arthritis Society at: 
http://www.rheumatoid.org.uk/
 Arthritis Research Campaign - ARC
Copeman House, St Marys Court, St Marys Gate, Chesterfield, 
Derbyshire, S41 7TD.
Tel: 0870 850 5000 Web: www.arc.org.uk
 Arthritis Care
18 Stephenson Way, London, NW1 2HD
Helpline: 0808 800 4050 Web: www.arthritiscare.org.uk
 National Rheumatoid Arthritis Society (NRAS)
Unit B4 Westacott Business Centre, Westacott Way, Littlewick
Green, Maidenhead, Berks, SL6 3RT
Helpline: 0800 298 7650 Web: www.rheumatoid.org.uk
 Podiatric Rheumatic Care Association
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